Somatic Diversification of Immunoglobulin Genes in Galt
Galt 免疫球蛋白基因的体细胞多样化
基本信息
- 批准号:8321129
- 负责人:
- 金额:$ 31.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-01 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenovirusesAgonistAntibody RepertoireAntigensB-LymphocytesBacteriaBacteroides fragilisBirthCD28 geneCTLA4 geneCell CommunicationCellsDendritic CellsDevelopmentDiseaseEpitheliumGene ConversionGenerationsGoalsGut associated lymphoid tissueHealthHumanHuman bodyHypersensitivityImmunofluorescence ImmunologicImmunoglobulin GenesImmunoglobulin Somatic HypermutationIn Situ HybridizationInflammatory Bowel DiseasesInterleukin-4IntestinesKineticsLymphoid TissueMucosal ImmunityNatureOrganismOryctolagus cuniculusPattern recognition receptorProcessRecombinantsSiteSterilitySuperantigensT-Cell ActivationT-LymphocyteTNFRSF5 geneTestingUp-RegulationVertebratesWorkactivation-induced cytidine deaminasebasecommensal microbescytokinedesignin vivomicroorganismmigrationmutantpreventreceptorresearch studyuptake
项目摘要
DESCRIPTION (provided by applicant): The intestinal commensal microbiota is required for development of lymphoid tissues and mucosal immunity in vertebrates. However, little is known of the mechanism by which these processes occur. Previous work in rabbits has demonstrated that the intestinal commensal microbiota is also required for somatic hypermutation (SHM) and gene conversion (GC) of Ig genes during development of the preimmune antibody repertoire, and for B cell selection, both of which occur in gut-associated lymphoid tissues (GALT). By introducing select bacterial strains into sterile GALT, we found that some but not all commensal organisms have the capacity to induce GALT development and SHM and GC of Ig genes. We identified two commensal microorganisms, B. fragilis and B. subtilis, that together, induced these processes; however, introduced singly, neither organism induced these processes. The goal of this study is to determine the mechanism by which these bacteria induce GALT development and SHM and GC of Ig genes, and why two bacteria are required. The first specific aim is to determine how bacteria enter the host, and if the difference in follicle-inducing bacteria and non-follicle-inducing bacteria resides in how they are taken up across the epithelium of GALT. Experiments to test this include introducing bacteria into germfree appendix and then performing in situ hybridization and immunofluorescence to determine in which cells the bacteria are localized. The next specific aim, by using soluble receptors expressed in recombinant adenovirus, will investigate whether dendritic cells (DC) contribute to GALT development and Ig gene diversification by secretion of the B cell growth factor, BAFF, or by inhibiting the transepithelial migration of DC in vivo. In Aim 3, the requirement for T cell help will be investigated by inhibiting the activation of T cells with soluble CTLA4 and B-T cell interactions with soluble CD40, both produced in recombinant adenovirus. In Aim 4, experiments are designed to search for a B cell superantigen that induces GALT development and somatic diversification of the primary antibody repertoire. These experiments are important because the lumen of the intestine contains 10X more bacterial cells than all other cells of the human body combined, and yet we know little about how these organisms contribute to human health and diseases such as allergy and inflammatory bowel disease.
描述(由申请人提供):肠道性菌群的肠道发育和脊椎动物中的粘膜免疫需要。但是,对于这些过程发生的机制知之甚少。兔子的先前工作表明,在免疫前抗体库发展过程中,Ig基因的体细胞超突变(SHM)和基因转化率(GC)也需要肠道分子菌群,而B细胞的选择也需要B细胞的选择,这两者都发生在肠肠gut菌相关的淋巴机(GALT)中。通过将精选细菌菌株引入无菌galt,我们发现某些但并非所有共生生物具有诱导Ig基因的Galt发育以及SHM和GC的能力。我们确定了两种共同的微生物,分布氏芽孢杆菌和枯草芽孢杆菌,它们共同诱导了这些过程。但是,单独提出,两种生物都没有诱导这些过程。这项研究的目的是确定这些细菌诱导galt发育以及Ig基因的SHM和GC的机制,以及为什么需要两种细菌。第一个具体目的是确定细菌如何进入宿主,以及卵泡诱导细菌和非卵泡诱导细菌的差异是否属于它们在Galt上皮上所吸收的方式。测试此测试的实验包括将细菌引入无收获的附录中,然后进行原位杂交和免疫荧光,以确定细菌在哪些细胞局部定位。下一个特定目标是使用在重组腺病毒中表达的可溶受体,将研究树突状细胞(DC)是通过分泌B细胞生长因子,BAFF还是抑制DC的transepithelial transepithelial in Vivo的分泌来促进GALT发育和Ig基因多样化。在AIM 3中,将通过抑制可溶性CTLA4和B-T细胞与可溶性CD40的T细胞的激活来研究T细胞帮助的需求,这均在重组腺病毒中产生。在AIM 4中,实验旨在寻找B细胞超抗原,该B细胞超抗原可引起galt的发育和主要抗体库的躯体多样化。这些实验很重要,因为肠道的腔含有比人体的所有其他细胞多的细菌细胞更多的细菌细胞,但是我们对这些生物的贡献对人类健康和疾病(例如过敏和炎症性肠病)的贡献知之甚少。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Katherine L. Knight其他文献
Genetic control of alpha chains of rabbit IgA: allotypic specificities on the variable and the constant regions.
兔 IgA α 链的遗传控制:可变区和恒定区的同种异型特异性。
- DOI:
- 发表时间:
1975 - 期刊:
- 影响因子:0
- 作者:
Katherine L. Knight;W. Hanly - 通讯作者:
W. Hanly
Exopolysaccharide-treated Dendritic Cells Effectively Ameliorate Acute Graft vs Host Disease.
胞外多糖处理的树突状细胞可有效改善急性移植物抗宿主病。
- DOI:
10.1016/j.jtct.2023.10.023 - 发表时间:
2023 - 期刊:
- 影响因子:3.2
- 作者:
O. Kalinina;L. Minter;Anne I. Sperling;M. K. Hollinger;Phong Le;Barbara A. Osborne;Shubin Zhang;Patrick Stiff;Katherine L. Knight - 通讯作者:
Katherine L. Knight
Intestinal bacteria and development of the B-lymphocyte repertoire
- DOI:
10.1016/j.it.2005.06.001 - 发表时间:
2005-08-01 - 期刊:
- 影响因子:
- 作者:
Dennis K. Lanning;Ki-Jong Rhee;Katherine L. Knight - 通讯作者:
Katherine L. Knight
Comparison of Two Hapten-specific Rabbit Antibodies
- DOI:
10.1016/s0021-9258(18)96618-4 - 发表时间:
1966-05-25 - 期刊:
- 影响因子:
- 作者:
Katherine L. Knight;Miguel Angel Lopez;Felix Haurowitz - 通讯作者:
Felix Haurowitz
Katherine L. Knight的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Katherine L. Knight', 18)}}的其他基金
Development of a mucosal vaccine to prevent Clostridium difficile infection using papilloma pseudovirus as a vector.
使用乳头状瘤假病毒作为载体开发粘膜疫苗以预防艰难梭菌感染。
- 批准号:
10213890 - 财政年份:2020
- 资助金额:
$ 31.32万 - 项目类别:
Prevention of GVHD by a probiotic exopolysaccharide.
通过益生菌胞外多糖预防 GVHD。
- 批准号:
10081555 - 财政年份:2020
- 资助金额:
$ 31.32万 - 项目类别:
Commensal Exopolysaccharide Protection from Inflammation
共生胞外多糖预防炎症
- 批准号:
8888736 - 财政年份:2015
- 资助金额:
$ 31.32万 - 项目类别:
Protection from enteric pathogens by beneficial microbes
通过有益微生物预防肠道病原体
- 批准号:
8546976 - 财政年份:2012
- 资助金额:
$ 31.32万 - 项目类别:
Protection from enteric pathogens by beneficial microbes
通过有益微生物预防肠道病原体
- 批准号:
8256331 - 财政年份:2012
- 资助金额:
$ 31.32万 - 项目类别:
Maintaining B cell immunity with aged B lymphocytes
用老化的 B 淋巴细胞维持 B 细胞免疫
- 批准号:
7878421 - 财政年份:2009
- 资助金额:
$ 31.32万 - 项目类别:
Maintaining B cell immunity with aged B lymphocytes
用老化的 B 淋巴细胞维持 B 细胞免疫
- 批准号:
8015990 - 财政年份:2007
- 资助金额:
$ 31.32万 - 项目类别:
Maintaining B cell immunity with aged B lymphocytes
用老化的 B 淋巴细胞维持 B 细胞免疫
- 批准号:
7365169 - 财政年份:2007
- 资助金额:
$ 31.32万 - 项目类别:
相似国自然基金
肝胆肿瘤治疗性溶瘤腺病毒疫苗的研制及其临床前应用性探索
- 批准号:82303776
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于sIgA的V(D)J结构多样性探索腺病毒载体鼻喷新冠奥密克戎疫苗诱导的呼吸道粘膜免疫原性特征
- 批准号:82302607
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
禽腺病毒血清11型反向遗传平台的建立与毒株间致病性差异机制探究
- 批准号:32372997
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
PD-1/PD-L1信号促CD21-B细胞BCR髓外二次编辑降低自身反应性在儿童腺病毒肺炎中的作用机制研究
- 批准号:82370015
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
CD46和DSG2双受体在人B组腺病毒感染与致病中的协同作用和机制研究
- 批准号:32370155
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 31.32万 - 项目类别:
Human-informed data-driven development of next-generation T cell vaccine against malaria
以人为本的数据驱动开发下一代抗疟疾 T 细胞疫苗
- 批准号:
10443906 - 财政年份:2022
- 资助金额:
$ 31.32万 - 项目类别:
Human-informed data-driven development of next-generation T cell vaccine against malaria
以人为本的数据驱动开发下一代抗疟疾 T 细胞疫苗
- 批准号:
10756179 - 财政年份:2022
- 资助金额:
$ 31.32万 - 项目类别:
KATP Channels as Downstream targets of adenylyl cyclases during opioid tolerance and withdrawal
KATP 通道作为阿片类药物耐受和戒断期间腺苷酸环化酶的下游靶标
- 批准号:
10451672 - 财政年份:2021
- 资助金额:
$ 31.32万 - 项目类别:
KATP Channels as Downstream targets of adenylyl cyclases during opioid tolerance and withdrawal
KATP 通道作为阿片类药物耐受和戒断期间腺苷酸环化酶的下游靶标
- 批准号:
10317189 - 财政年份:2021
- 资助金额:
$ 31.32万 - 项目类别: